PK Effects of SHR4640 on Repaglinide and Midazolam, and the Impact of SHR4640 on QT Interval

NCT06196580 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout and Hyperuricemia

Interventions

DRUG: repaglinide; midazolam; SHR4640
DRUG: repaglinide; midazolam; SHR4640; SHR4640 placebo
DRUG: repaglinide; midazolam; SHR4640 placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.